©The Author(s) 2025.
World J Gastrointest Endosc. Dec 16, 2025; 17(12): 111872
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111872
Published online Dec 16, 2025. doi: 10.4253/wjge.v17.i12.111872
Table 2 Patient performance metrics
| Characteristic | P value | |
| Treatment interval (days) | 499 | |
| Number of EGDs | 3.51 | |
| Treatments | ||
| EBL | 1.46 | |
| No. bands deployed | 6.32 | |
| RFA | 0.51 | |
| APC | 1.49 | |
| Hemoglobin | < 0.001 | |
| Pre-treatment | 8.7 | |
| Post-treatment | 10.9 | |
| Ferritin | 0.851 | |
| Pre-treatment | 98.7 | |
| Post-treatment | 90.2 | |
| Transferrin saturation | 0.014 | |
| Pre-treatment | 21.1 | |
| Post-treatment | 47.8 | |
| Transfusions | < 0.001 | |
| Pre-treatment | 1.55 | |
| Post-treatment | 0.19 | |
| Hospitalizations | < 0.001 | |
| Pre-treatment | 1.14 | |
| Post-treatment | 0.24 | |
| Clinical remission rate | 84.0% | |
| Endoscopic remission rate | 48.7% |
- Citation: Cooper JA, Statham E, Holyfield A, Shoreibah MG, Peter S. Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies. World J Gastrointest Endosc 2025; 17(12): 111872
- URL: https://www.wjgnet.com/1948-5190/full/v17/i12/111872.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i12.111872